Barclays analyst Brian Johnson maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $54 to $53.
Barclays Maintains Overweight on Adient, Lowers Price Target to $53
Barclays analyst Brian Johnson maintains Adient (NYSE:ADNT) with a Overweight and lowers the price target from $54 to $53.
Related Posts
American Electric Power Company Announced That Effective Nov 1, Position Of Executive Vice President And COO Will Be Eliminated; Lisa Barton Will Remain At AEP With Transitional Responsibilities, Reporting To Akins, Until Nov. 1
COLUMBUS, Ohio, Sept. 22, 2022 /PRNewswire/ -- American Electric Power (NASDAQ:AEP) has made organizational and executive leadership changes to support the company's strategic priorities and executive
SoftBank Group Raises $22B Through Deals That Would Slash Its Alibaba Stake
Japanese multinational conglomerate SoftBank Group Corp (OTC: SFTBY) has raised $22 billion in cash through deals that would significantly trim its stake in Alibaba Group Holding Ltd. (NYSE: BABA
Chubb Announced Late Thursday it Will Acquire Cigna’s $3B Premium Revenue Personal Accident, Supplemental Health and Life Insurance Business in Seven Asia-Pacific Markets for $5.75B
Chubb Limited (NYSE: CB) today announced a definitive agreement to acquire the life and non-life insurance companies that house the personal accident, supplemental health and life insurance business of Cigna (NYSE: CI) in seven Asia-Pacific markets for $5.75 billi